Back to Browse Journals » Clinical Interventions in Aging » Volume 3 » Issue 2

Lubiprostone: a novel treatment for chronic constipation

Authors Brian E Lacy, L Campbell Levy

Published Date June 2008 Volume 2008:3(2) Pages 357—364

DOI http://dx.doi.org/10.2147/CIA.S2938

Published 30 June 2008

Brian E Lacy, L Campbell Levy

Section of Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon NH, USA

Abstract: Chronic constipation is highly prevalent, reduces patients’ quality of life, and imposes a significant health care burden on society. Lifestyle modifications and over-the-counter agents improve symptoms of constipation in some patients, however many patients have persistent symptoms and require the use of prescription medications. Three prescription medications are currently Food and Drug Administration (FDA) approved and available for the treatment of chronic constipation in adults. This review will focus on lubiprostone, the newest medication available for the treatment of chronic constipation. Lubiprostone is a bicyclic fatty acid metabolite analogue of prostaglandin E1. It activates specific chloride channels in the gastrointestinal tract to stimulate intestinal fluid secretion, increase gastrointestinal transit, and improve symptoms of constipation. This article will provide a brief overview on chloride channel function in the gastrointestinal tract, describe the structure, function, and pharmacokinetics of lubiprostone, and discuss the safety and efficacy of this new medication.

Keywords: chloride, chloride channels, constipation, functional bowel disorders, gastrointestinal motility, intestinal secretion, irritable bowel syndrome, lubiprostone

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Mitochondrial dysfunction, oxidative stress, and major depressive disorder

Tobe EH

Neuropsychiatric Disease and Treatment 2013, 9:567-573

Published Date: 26 April 2013

Paclitaxel-Fe3O4 nanoparticles inhibit growth of CD138–  CD34– tumor stem-like cells in multiple myeloma-bearing mice

Yang C, Wang J, Chen D, Chen J, Xiong F, Zhang H, Zhang Y, Gu N, Dou J

International Journal of Nanomedicine 2013, 8:1439-1449

Published Date: 12 April 2013

Size- and charge-dependent non-specific uptake of PEGylated nanoparticles by macrophages

Yu SS, Lau CM, Thomas SN, Jerome WG, Maron DJ, Dickerson JH, Hubbell JA, Giorgio TD

International Journal of Nanomedicine 2012, 7:799-813

Published Date: 15 February 2012

Subtle cytotoxicity and genotoxicity differences in superparamagnetic iron oxide nanoparticles coated with various functional groups

Hong SC, Lee JH, Lee J, Kim HY, Park JY, Cho J, Lee J, Han DW

International Journal of Nanomedicine 2011, 6:3219-3231

Published Date: 7 December 2011

Eudragit nanoparticles containing genistein: formulation, development, and bioavailability assessment

Tang J, Xu N, Ji H, Liu H, Wang Z, Wu L

International Journal of Nanomedicine 2011, 6:2429-2435

Published Date: 19 October 2011

Role of paliperidone extended-release in treatment of schizoaffective disorder

Carla M Canuso, Ibrahim Turkoz, Dong Jing Fu, et al

Neuropsychiatric Disease and Treatment 2010, 6:667-679

Published Date: 28 September 2010

Hyaluronic acid gel (Juvéderm™) preparations in the treatment of facial wrinkles and folds

Inja Bogdan Allemann, Leslie Baumann

Clinical Interventions in Aging 2008, 3:629-634

Published Date: 22 January 2009

Glucosamine hydrochloride for the treatment of osteoarthritis symptoms

Beth Anne Fox, Mary M Stephens

Clinical Interventions in Aging 2007, 2:599-604

Published Date: 3 January 2007